There was a statistical trend for thromboembolic complications in patients with cervical and/or intracranial atherosclerosis (p = 0.07), but age was not associated with them (p = 0.93). Patients who received heparin had lower rates of embolic complications than those who did not receive it, but...
Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort study. Lancet Neurol. 6, 595–603 (2007). Article PubMed PubMed Central Google Scholar Miranda, B. et al. Venous thromboembolic events after ...
Risk factors for thromboembolic stroke in elderly patients with chronic atrial fibrillation. American Journal of Cardiology 63: 366–367, 1989Aronow WS, Gutstein H, Fsieh FY. Risk factors for thromboembolic stroke in elderly patients with chronic atrial fibrillation. Am J Cardiol . 1989;63: 366–...
Background: Cerebral thromboembolic complications remain one of the most severe complications of catheter ablation of atrial ibrillation (AF). However, due to different ablation approaches, energy sources and peri-interventional management there is inconsistent data on incidence, characteristics and outcome...
Thromboembolic complications including cerebrovascular accidents, pulmonary embolism, myocardial infarction, deep vein thrombosis and disseminating intrava... HM Alnafea,AA Korish - 《Blood Coagulation & Fibrinolysis An International Journal in Haemostasis & Thrombosis》 被引量: 0发表: 2023年 Relative risk...
eiden mutation and the risks for thromboembolic disease: a clinical perspective. Ann Intern Med, 127 (1997), pp. 895-903 CrossrefView in ScopusGoogle Scholar 49 M Den Heijer, FR Rosendaal, HJ Blom, WB Gerrits, GM Bos Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb Haemo...
Direct oral anticoagulants (DOACs) have already established benefit over warfarin as a long-term treatment of symptomatic venous thromboembolic disorder like deep vein thrombosis (DVT), and pulmonary embolism (PE) given its equal efficacy and better safety profile. The benefit of DOACs over warfarin ...
Cerebral venous sinus thrombosis is a rare stroke with several clinical manifestations. Several studies have identified prognostic risk factors associated with poor functional outcomes and established predictive models. This systematic review and meta-an
Cancer and cisplatin chemotherapy are well-known risk factors for thromboembolic events. The therapeutic strategy is an anticoagulant therapy. Symptoms are usually reversible within weeks under this therapy. Therefore, in patients with testicular cancer and chemotherapy who present with neurological symptoms...
Zhu L, Cheng J, Gu P, Liu Y, Liu J, Wang J, Shen H. Therapeutic strategies of thromboembolic events in patients with inflammatory bowel diseases: Two case reports. Medicine. 2019 Mar:98(9):e14622. doi: 10.1097/MD.0000000000014622. Epub[PubMed PMID: 30817579] ...